Switch View
© PR Newswire
17.10.2025
ISIN: US64125C1099
Neurocrine Biosciences Inc
NBIX
LISTED
NASDAQ
Neurocrine Biosciences Presents New KINECT® 4 Post-Hoc Analysis Demonstrating Rapid and Sustained Therapeutic Efficacy of INGREZZA® (valbenazine) 40 mg Capsules
News Preview
Continuous treatment with INGREZZA 40 mg for 48 weeks resulted in sustained, clinically meaningful improvements in tardive dyskinesia symptoms
90% of participants who completed 48 weeks of continuous treatment with INGREZZA 40 mg achieved a ≥50% improvement in the Abnormal Involuntary Movement S...
Themefolio
Profiler
Peergroup
© PR Newswire
17.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
News Preview
MLTX Investors with Losses Encouraged to Contact the Firm
SAN FRANCISCO, Oct. 17, 2025 /PRNewswire/ -- A securities class action, styled Bridgewood v. MoonLake Immunotherapeutics, et al., No. 1:25-cv-08500 (S.D.N.Y), has been filed after MoonLake (NASDAQ: MLTX) announced disastrous Phase 3 trial r...
Themefolio
Profiler
Peergroup
© Newsfile
17.10.2025
ISIN: CA71716H1082
PharmaTher Holdings Ltd.
PHRM
LISTED
CSE
PharmaTher Applauds FDA's Commissioner's National Priority Voucher (CNPV) Selection of Ketamine; Company Highlights Potential Ketamine Opportunity, 505(b)(2) Focus, and Upside from Strategic ANDA Sale
News Preview
Toronto, Ontario--(Newsfile Corp. - October 17, 2025) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty life sciences company focused on unlocking the pharmaceutical potential of ketamine, today applauds the U.S. Food and Drug Administration's ("FDA") announcement on October 16, 2025 of the first-eve...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
17.10.2025
ISIN: US1241551027
Butterfly Network Inc
BFLY
LISTED
NYSE
Butterfly Network to Report Third Quarter 2025 Financial Results on October 31, 2025
News Preview
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will report third quarter 2025 financial results on October 31, 2025 before the market opens.
Joseph DeVivo, President, Chief Executive Officer and Chairman of the Boa...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
17.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Announces Chief Medical Officer (CMO) Transition
News Preview
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced Yasmine Wasfi, M.D., Ph.D., FCCP has been promoted to CMO, effective immediately. She succeeds Ray Pratt, M.D., FACP who will transition from his current role to Senior Medical Advisor. Dr. Wasfi will report di...
Themefolio
Profiler
Peergroup
© PR Newswire
17.10.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
OpenEvidence und Veeva verkünden Open Vista-Partnerschaft
News Preview
PLEASANTON, Kalifornien, und MIAMI, 17. Oktober 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) und OpenEvidence gaben heute die Gründung einer langfristigen Partnerschaft bekannt, um gemeinsam Open Vista zu entwickeln und zu vermarkten. Open Vista wird KI einsetzen, um Patienten den Zugang zu klinischen Studien...
Themefolio
Profiler
Peergroup
© PR Newswire
17.10.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly's Verzenio® (abemaciclib) prolonged survival in HR+, HER2-, high-risk early breast cancer with two years of treatment
News Preview
Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk early breast cancer
Seven-year results from the Phase 3 monarchE trial also show Verzenio plus endocrine therap...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.10.2025
ISIN: US2210151005
Corvus Pharmaceuticals Inc
CRVS
LISTED
NASDAQ
Corvus Pharmaceuticals Announces Presentation of Interim Data from the Phase 1b/2 Clinical Trial of Ciforadenant for Patients with Metastatic Renal Cell Cancer at the European Society for Medical Oncology (ESMO) Congress 2025
News Preview
Trial is evaluating ciforadenant as a potential first line therapy for metastatic renal cell cancer (RCC) in combination with ipilimumab (anti-CTLA-4) and nivolumab (anti-PD-1)...
Themefolio
Profiler
Peergroup
© BusinessWire
17.10.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
Broadwood Partners Issues Letter to STAAR Surgical’s Board Urging it to Allow Timely Shareholder Vote on Alcon Sale
News Preview
Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today issued the following letter to the Board of Directors (the “Board”) of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Broadwood, which owns 27.5% of STAAR’s outstanding common shares, urges its fellow shareholders to vote on its GREEN Proxy Card “AGAIN...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.10.2025
ISIN: US92337R1014
Vera Therapeutics Inc
VERA
LISTED
NASDAQ
Vera Therapeutics Announces ORIGIN 3 Late-Breaking Abstract Selected as Featured Oral Presentation at Opening Plenary Session of ASN Kidney Week 2025
News Preview
Vera Therapeutics Announces ORIGIN 3 Late-Breaking Abstract Selected as Featured Oral Presentation at Opening Plenary Session of ASN Kidney Week 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
17.10.2025
ISIN: US4576693075
Insmed Inc
INSM
LISTED
NASDAQ
CHMP Recommends EU Approval of BRINSUPRI™ (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis
News Preview
— If Approved, BRINSUPRI Would Be the First and Only Treatment in the European Union for Non-Cystic Fibrosis Bronchiectasis (NCFB) and the First-in-Class DPPI Inhibitor Targeting Neutrophilic Inflammation
— BRINSUPRI Was Reviewed Under CHMP's Accelerated Assessment Pathway as It...
Themefolio
Profiler
Peergroup
© PR Newswire
17.10.2025
ISIN: US1011371077
Boston Scientific Corp
BSX
LISTED
NYSE
Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.
News Preview
Acquisition to expand the neuromodulation offerings for people living with chronic pain
MARLBOROUGH, Mass., Oct. 17, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Nalu Medical...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
17.10.2025
ISIN: US2546041011
Disc Medicine Inc
IRON
LISTED
NASDAQ
Disc Medicine to Present Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2025 American Society of Nephrology (ASN) Kidney Week
News Preview
WATERTOWN, Mass., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced it will present clinical data as a poster presentation at the u...
Themefolio
Profiler
Peergroup
© BusinessWire
17.10.2025
ISIN: US86627T1088
Summit Therapeutics Inc
SMMT
LISTED
NASDAQ
Summit Therapeutics Announces Expansion of Ivonescimab Global Phase III Development Program with HARMONi-GI3 Study in 1L Colorectal Cancer
News Preview
Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the expansion of its Phase III clinical development program of the novel, potential first-in-class investigational bispecific antibody, ivonescimab, into colorectal cancer (CRC) with the initiation of the global Phase III HARMONi-GI3 trial.
Summit is start...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.10.2025
ISIN: GB00BMVP7Y09
Royalty Pharma PLC
RPRX
LISTED
NASDAQ
Royalty Pharma Declares Fourth Quarter 2025 Dividend
News Preview
NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2025 of $0.22 per Class A ordinary share....
Themefolio
Profiler
Peergroup
© PR Newswire
17.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH INVESTOR DEADLINE: Molina Healthcare, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
News Preview
SAN DIEGO, Oct. 17, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Molina Healthcare, Inc. (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, inclusive (the "Class Period"), have until Tuesday, December 2, 2025 to seek appointment as lead plaint...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.10.2025
ISIN: US00847X1046
Agios Pharmaceuticals Inc
AGIO
LISTED
NASDAQ
Agios’ PYRUKYND® (mitapivat) Receives Positive CHMP Opinion for Adults with Thalassemia
News Preview
Agios today announced that the CHMP has adopted a positive opinion for the new indication for PYRUKYND in adults for anemia associated with thalassemia...
Themefolio
Profiler
Peergroup
© Newsfile
17.10.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group's iQ Food Co. Announces Grand Opening of Newest Location in Toronto's Avenue & Lawrence Neighbourhood
News Preview
Toronto, Ontario--(Newsfile Corp. - October 17, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands across Canada, is pleased to announce that, further to its June 18th, 2025 news release announcing the signing of a franchise agreement and real estat...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.10.2025
ISIN: US7530181004
Rani Therapeutics Holdings, Inc.
RANI
LISTED
NASDAQ
Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules
News Preview
SAN JOSE, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it has entered into a securities purchase agreement with certain institutional and accredited invest...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.10.2025
ISIN: US7530181004
Rani Therapeutics Holdings, Inc.
RANI
LISTED
NASDAQ
Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing
News Preview
SAN JOSE, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it has entered into a Collaboration and License Agreement with Chugai Pharmaceutical Co., Ltd. ("Chu...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.10.2025
ISIN: US0044685008
Achieve Life Sciences, Inc.
ACHV
LISTED
NASDAQ
Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation
News Preview
Potential First-in-Class Treatment for Nicotine E-cigarette or Vaping Cessation Receives Unprecedented Expedited Review Pathway...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.10.2025
ISIN: US75886F1075
Regeneron Pharmaceuticals Inc
REGN
LISTED
NASDAQ
Libtayo® (cemiplimab) Recommended for EU Approval by the CHMP for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with a High Risk of Recurrence After Surgery and Radiation
News Preview
Positive opinion based on results of Phase 3 C-POST trial that show Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to placebo (hazard ratio: 0.32; 95% confidence interval: 0.20-0.51; p...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.10.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia
News Preview
Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.10.2025
ISIN: US88688T1007
Tilray Brands Inc
TLRY
LISTED
TSX
Tilray Brands Marks Seven Years of Cannabis Legalization in Canada with the #1 Market-Leading Position by Revenue and Pioneering Brands with Growing Market Share in the World’s Largest Federally Legal Cannabis Market
News Preview
TORONTO, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the global cannabis, beverage, and wellness industries, proudly celebrates the seventh anniversary of cannabis legalization in Canada. As the largest feder...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.10.2025
ISIN: US82657M1053
Sight Sciences Inc
SGHT
LISTED
NASDAQ
Sight Sciences Announces Fee Schedule Establishment from Novitas Solutions and First Coast Service Options for the TearCare® Interventional Dry Eye Procedure
News Preview
MENLO PARK, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today announced that two Medicare Administrative Contract...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.10.2025
ISIN: US28617K1016
Eledon Pharmaceuticals, Inc.
ELDN
LISTED
NASDAQ
Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annual Meeting
News Preview
Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at Kidney Week...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.10.2025
ISIN: US28658R1068
Climb Bio, Inc
CLYM
LISTED
NASDAQ
Climb Bio to Present Data at American Society of Nephrology (ASN) Kidney Week 2025
News Preview
Preclinical data for CLYM116, anti-APRIL monoclonal antibody, highlight favorable pharmacokinetic and pharmacodynamic profile, supporting development for IgA nephropathy (IgAN)...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.10.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Press Release: Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease
News Preview
Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.10.2025
ISIN: CH0012032048
Roche Holding AG
ROG
LISTED
SIX
CHMP recommends EU approval of Roche’s Gazyva/Gazyvaro for lupus nephritis
News Preview
Basel, 17 October, 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Gazyva®/Gazyvaro® (obinutuzumab) in combination with mycophenolate mofetil (MMF) for the treatment of adult patients with active Class III or IV, with...
Themefolio
Profiler
Peergroup
© PR Newswire
17.10.2025
ISIN: US44975P1030
I-Mab
IMAB
LISTED
NASDAQ
I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences
News Preview
New business model reflects strategic transition to a global biotech platform focused on business development and translational clinical development to accelerate access to innovative medicines for patients worldwide
Intention to pursue a Hong Kong initial public offering (IPO) to expand access...
Themefolio
Profiler
Peergroup
© PR Newswire
17.10.2025
ISIN: US74834L1008
Quest Diagnostics Inc
DGX
LISTED
NYSE
MVZ HPH Brings ctDNA Blood Test for Cancer Monitoring to Europe, Based on Haystack MRD® Technology from Quest Diagnostics®
News Preview
Blood test to aid cancer treatment and recurrence monitoring now available from a German lab for potentially faster results
HAMBURG, Germany, Oct. 17, 2025 /PRNewswire/ -- MVZ HPH Institute for Pathology and Hematopatholo...
Themefolio
Profiler
Peergroup
© PR Newswire
17.10.2025
ISIN: KR7068270008
Celltrion Inc
68270
LISTED
KSC
FDA approves expanded pediatric indications for YUFLYMA® (adalimumab-aaty) and unbranded adalimumab-aaty in the United States
News Preview
YUFLYMA®
(adalimumab-aaty), and its unbranded version, are now approved for
two additional pediatric indications – adolescent hidradenitis suppurativa (HS) and pediatric uveitis (UV), in the U.S.
[1]...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.10.2025
ISIN: BE0003766806
Ion Beam Applications SA
IBAB
LISTED
EURONEXT
IBA opens the world of science and technology to secondary school girls
News Preview
Its Innovat’her event brought together female students to explore careers in STEM...
Themefolio
Profiler
Peergroup
© PR Newswire
17.10.2025
ISIN: US4523271090
Illumina Inc
ILMN
LISTED
NASDAQ
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
News Preview
Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx
Constellation outperformed orthogonal methods in identifying select difficult-to-map variants
SAN DIEGO, Oct. 17, 2...
Themefolio
Profiler
Peergroup
© PR Newswire
17.10.2025
ISIN: US4523271090
Illumina Inc
ILMN
LISTED
NASDAQ
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
News Preview
Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx
Constellation outperformed orthogonal methods in identifying select difficult-to-map variants
SAN DIEGO, Oct. 17, 2...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.10.2025
ISIN: US74006W1080
Praxis Precision Medicines Inc
PRAX
LISTED
NASDAQ
Praxis Precision Medicines, Inc. Announces Pricing of $525 Million Public Offering
News Preview
BOSTON, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced the pricing of its underwritten p...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.10.2025
ISIN: US52886X1072
Lexeo Therapeutics Inc
LXEO
LISTED
NASDAQ
Lexeo Therapeutics Announces Pricing of Public Offering and Concurrent Private Placement
News Preview
Lexeo Therapeutics Announces Pricing of Public Offering and Concurrent Private Placement...
Themefolio
Profiler
Peergroup
© PR Newswire
17.10.2025
ISIN: US2197981051
QuidelOrtho Corp
QDEL
LISTED
NASDAQ
QuidelOrtho Showcases Leadership in Transfusion Medicine at AABB 2025
News Preview
FDA-approved MTS™ DAT Card and advanced ORTHO VISION™ Platform highlight the company's continued leadership in transfusion medicine
SAN DIEGO, Oct. 16, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, will hig...
Themefolio
Profiler
Peergroup
© BusinessWire
17.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Labaton Keller Sucharow LLP Files Securities Class Action Against Baxter International, Inc. and Certain of Its Executives
News Preview
Labaton Keller Sucharow LLP (“Labaton”) has filed a securities class action lawsuit (the “Action”) on behalf of its client the Electrical Workers Pension Fund, Local 103, I.B.E.W. (“Local 103”) against Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) and certain of its executives (collectively, “Defendants”). The Action, which is...
Themefolio
Profiler
Peergroup
© BusinessWire
17.10.2025
ISIN: US00857U1079
agilon health inc
AGL
LISTED
NYSE
Rosen Law Firm Encourages agilon health, inc. Investors to Inquire About Securities Class Action Investigation – AGL
News Preview
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public.
So What: If you purchased agilon health se...
Themefolio
Profiler
Peergroup
© BusinessWire
17.10.2025
ISIN: US8753722037
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation – TNDM
News Preview
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued materially misleading business information to the investing public.
So What: If you purchased...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.10.2025
ISIN: US76155X1000
Revolution Medicines Inc
RVMD
LISTED
NASDAQ
Revolution Medicines Awarded Voucher for Daraxonrasib (RMC-6236) Under FDA Commissioner's National Priority Voucher Pilot Program
News Preview
REDWOOD CITY, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted a non-transferrable voucher for daraxonrasib (RMC-6236), the co...
Themefolio
Profiler
Peergroup
© Newsfile
17.10.2025
ISIN: CA62858B1085
MyndTec Inc.
MYTC
LISTED
CSE
MyndTec Inc. Completes Sixth Tranche of Non-Brokered Private Placement
News Preview
Mississauga, Ontario--(Newsfile Corp. - October 16, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a neurological treatment and rehabilitation medical technology company, is pleased to announce that it has closed the sixth tranche of its non-brokered private placement previously announced on January 30, 2025 (the "Offering"). The si...
Themefolio
Profiler
Peergroup
© BusinessWire
17.10.2025
ISIN: US28176E1082
Edwards Lifesciences Corp.
EW
LISTED
NYSE
EW Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
News Preview
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the directors and officers of Edwards Lifesciences Corporation (NYSE: EW).
If you currently own shares of Edwards stock, please visit the firm’s website at https://rosenlegal.com/submit-form/?case_id=29704 for more informati...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
Berger Montague PC Investigating Claims on Behalf of MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors After Class Action Filing
News Preview
PHILADELPHIA, Oct. 16, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against MoonLake Immunotherapeutics (NASDAQ: MLTX) ("MoonLake" or the "Company") on behalf of investors who purchased MoonLake shares during the period of March 10, 2024 through September...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US0905722072
Bio Rad Laboratories, Inc.
BIO
LISTED
NYSE
Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025
News Preview
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the third quarter of 2025 on Wednesday, October 29, 2025, following the close of the market. Management will discuss these results in a conference call scheduled for 2:00 PM Pacific Tim...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US8292141053
Simulations Plus Inc
SLP
LISTED
NASDAQ
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation – SLP
News Preview
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.
So What: If you purchased Simulations P...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Nutex Health Inc. (NUTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 16, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US1266501006
CVS Health Corp
CVS
LISTED
NYSE
CVS Health Helps Improve Access to More Affordable Fertility Treatments
News Preview
WOONSOCKET, R.I., Oct. 16, 2025 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced it will support simpler access to more affordable fertility treatments for all Americans through its CVS Specialty Pharmacy and make it easier to pick up fertility medication at its 9,000 community pharmacy locations....
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US29261A1007
Encompass Health Corp
EHC
LISTED
NYSE
Rosen Law Firm Encourages Encompass Health Corporation Investors to Inquire About Securities Class Action Investigation – EHC
News Preview
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Encompass Health Corporation (NYSE: EHC) resulting from allegations that Encompass Health may have issued materially misleading business information to the investing public.
So What: If you purchased Enco...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US28414H1032
Elanco Animal Health Inc
ELAN
LISTED
NYSE
Elanco to Host Investor Day on December 9
News Preview
INDIANAPOLIS, Oct. 16, 2025 /PRNewswire/ -- Elanco Animal Health, Inc. (NYSE: ELAN) will host an Investor Day on Tuesday, December 9, 2025, from approximately 9 a.m. to 12 p.m. Eastern Time in New York City. The event will feature presentations from Elanco's senior leadership team on the company's strategic prior...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US86150R1077
Stoke Therapeutics Inc
STOK
LISTED
NASDAQ
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
News Preview
Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effe...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: AU000000AVH4
Avita Medical Inc.
AVH
LISTED
ASX
AVITA Medical Announces CEO Transition
News Preview
VALENCIA, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical”, or the “Company”), a leading therapeutic acute wound care company, today announced that the Board of Directors has named Chairman of the Board Cary Vance as Interim Chief Executive Officer, effective immediately. In conjunction with...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US29332G1022
Enhabit Inc
EHAB
LISTED
NYSE
Enhabit Home Health & Hospice Announces Date of 2025 Third Quarter Earnings Call
News Preview
Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its financial results for the third quarter ended Sept. 30, 2025, on Nov. 5, 2025, and host a webcast and conference call on Nov. 6, 2025. Individuals who would like to participate in the conference call webcast should join 15 minutes be...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
STAAR Surgical Affirms that No Acquisition Proposals Have Been Received From Any Party Other Than Alcon
News Preview
STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today issued the following statement:
Broadwood Partners’ statements and assertions regarding interest in STAAR are misleading and distort the truth. Broadwood is misrepresenting...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US02081G2012
Alphatec Holdings Inc
ATEC
LISTED
NASDAQ
ATEC to Report Third Quarter 2025 Financial Results on October 30, 2025
News Preview
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report third quarter 2025 financial results on October 30, 2025, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET.
Webcast
To acc...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US83444M1018
Solventum Corporation
SOLV
LISTED
NYSE
Solventum to Report Third Quarter Fiscal 2025 Earnings on November 6, 2025
News Preview
ST. PAUL, Minn., Oct. 16, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its third quarter fiscal 2025 financial results on Thursday, Nov. 6, 2025, after the U.S. financial markets close. After the release, Solventum management will host a webcast to discuss the results and its business. Other forward-l...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US49372L2097
Kezar Life Sciences Inc
KZR
LISTED
NASDAQ
Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis and Plans to Explore Strategic Alternatives
News Preview
Kezar Life Sciences, Inc. (Nasdaq: KZR, the Company), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced regulatory updates and the initiation of a process to explore a full range of strategic alternatives focused on maximizing shareholder value. The...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: GB00BRS65X63
Indivior plc
INDV
LISTED
LSE
Indivior to Report Third Quarter 2025 Financial Results and Host Webcast on October 30th
News Preview
RICHMOND, Va., Oct. 16, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) today announced that it will report its third quarter 2025 financial results on Thursday, October 30, 2025, at 7:00 a.m. U.S. ET. Following the release of the financial results, Joe Ciaffoni, Chief Executive Officer, and other members of Ind...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US26622P1075
Doximity Inc
DOCS
LISTED
NYSE
Doximity to Release Fiscal 2026 Second Quarter Results on November 6, 2025
News Preview
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter ended September 30, 2025 after market close on November 6, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
